Cargando…

Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy

Criteria for diagnosis of arrhythmogenic cardiomyopathy (ACM) were first proposed in 1994 and revised in 2010 by a Task Force. Although the Task Force criteria demonstrated a good accuracy for diagnosis of the original right ventricular phenotype (arrhythmogenic right ventricular cardiomyopathy), th...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrado, Domenico, Zorzi, Alessandro, Cipriani, Alberto, Bauce, Barbara, Bariani, Riccardo, Beffagna, Giorgia, De Lazzari, Manuel, Migliore, Federico, Pilichou, Kalliopi, Rampazzo, Alessandra, Rigato, Ilaria, Rizzo, Stefania, Thiene, Gaetano, Perazzolo Marra, Martina, Basso, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649536/
https://www.ncbi.nlm.nih.gov/pubmed/34533054
http://dx.doi.org/10.1161/JAHA.121.021987
_version_ 1784611017222782976
author Corrado, Domenico
Zorzi, Alessandro
Cipriani, Alberto
Bauce, Barbara
Bariani, Riccardo
Beffagna, Giorgia
De Lazzari, Manuel
Migliore, Federico
Pilichou, Kalliopi
Rampazzo, Alessandra
Rigato, Ilaria
Rizzo, Stefania
Thiene, Gaetano
Perazzolo Marra, Martina
Basso, Cristina
author_facet Corrado, Domenico
Zorzi, Alessandro
Cipriani, Alberto
Bauce, Barbara
Bariani, Riccardo
Beffagna, Giorgia
De Lazzari, Manuel
Migliore, Federico
Pilichou, Kalliopi
Rampazzo, Alessandra
Rigato, Ilaria
Rizzo, Stefania
Thiene, Gaetano
Perazzolo Marra, Martina
Basso, Cristina
author_sort Corrado, Domenico
collection PubMed
description Criteria for diagnosis of arrhythmogenic cardiomyopathy (ACM) were first proposed in 1994 and revised in 2010 by a Task Force. Although the Task Force criteria demonstrated a good accuracy for diagnosis of the original right ventricular phenotype (arrhythmogenic right ventricular cardiomyopathy), they lacked sensitivity for identification of the expanding phenotypic spectrum of ACM, which includes left‐sided variants and did not incorporate late‐gadolinium enhancement findings by cardiac magnetic resonance. The 2020 International criteria (“Padua criteria”) have been developed by International experts with the aim to improve the diagnosis of ACM by providing new criteria for the diagnosis of left ventricular phenotypic features. The key upgrade was the incorporation of tissue characterization findings by cardiac magnetic resonance for noninvasive detection of late‐gadolinium enhancement/myocardial fibrosis that are determinants for characterization of arrhythmogenic biventricular and left ventricular cardiomyopathy. The 2020 International criteria are heavily dependent on cardiac magnetic resonance, which has become mandatory to characterize the ACM phenotype and to exclude other diagnoses. New criteria regarding left ventricular depolarization and repolarization ECG abnormalities and ventricular arrhythmias of left ventricular origin were also provided. This article reviews the evolving approach to diagnosis of ACM, going back to the 1994 and 2010 International Task Force criteria and then grapple with the modern 2020 International criteria.
format Online
Article
Text
id pubmed-8649536
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86495362021-12-20 Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy Corrado, Domenico Zorzi, Alessandro Cipriani, Alberto Bauce, Barbara Bariani, Riccardo Beffagna, Giorgia De Lazzari, Manuel Migliore, Federico Pilichou, Kalliopi Rampazzo, Alessandra Rigato, Ilaria Rizzo, Stefania Thiene, Gaetano Perazzolo Marra, Martina Basso, Cristina J Am Heart Assoc Contemporary Review Criteria for diagnosis of arrhythmogenic cardiomyopathy (ACM) were first proposed in 1994 and revised in 2010 by a Task Force. Although the Task Force criteria demonstrated a good accuracy for diagnosis of the original right ventricular phenotype (arrhythmogenic right ventricular cardiomyopathy), they lacked sensitivity for identification of the expanding phenotypic spectrum of ACM, which includes left‐sided variants and did not incorporate late‐gadolinium enhancement findings by cardiac magnetic resonance. The 2020 International criteria (“Padua criteria”) have been developed by International experts with the aim to improve the diagnosis of ACM by providing new criteria for the diagnosis of left ventricular phenotypic features. The key upgrade was the incorporation of tissue characterization findings by cardiac magnetic resonance for noninvasive detection of late‐gadolinium enhancement/myocardial fibrosis that are determinants for characterization of arrhythmogenic biventricular and left ventricular cardiomyopathy. The 2020 International criteria are heavily dependent on cardiac magnetic resonance, which has become mandatory to characterize the ACM phenotype and to exclude other diagnoses. New criteria regarding left ventricular depolarization and repolarization ECG abnormalities and ventricular arrhythmias of left ventricular origin were also provided. This article reviews the evolving approach to diagnosis of ACM, going back to the 1994 and 2010 International Task Force criteria and then grapple with the modern 2020 International criteria. John Wiley and Sons Inc. 2021-09-17 /pmc/articles/PMC8649536/ /pubmed/34533054 http://dx.doi.org/10.1161/JAHA.121.021987 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Contemporary Review
Corrado, Domenico
Zorzi, Alessandro
Cipriani, Alberto
Bauce, Barbara
Bariani, Riccardo
Beffagna, Giorgia
De Lazzari, Manuel
Migliore, Federico
Pilichou, Kalliopi
Rampazzo, Alessandra
Rigato, Ilaria
Rizzo, Stefania
Thiene, Gaetano
Perazzolo Marra, Martina
Basso, Cristina
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
title Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
title_full Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
title_fullStr Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
title_full_unstemmed Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
title_short Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
title_sort evolving diagnostic criteria for arrhythmogenic cardiomyopathy
topic Contemporary Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649536/
https://www.ncbi.nlm.nih.gov/pubmed/34533054
http://dx.doi.org/10.1161/JAHA.121.021987
work_keys_str_mv AT corradodomenico evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT zorzialessandro evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT ciprianialberto evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT baucebarbara evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT barianiriccardo evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT beffagnagiorgia evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT delazzarimanuel evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT migliorefederico evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT pilichoukalliopi evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT rampazzoalessandra evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT rigatoilaria evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT rizzostefania evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT thienegaetano evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT perazzolomarramartina evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy
AT bassocristina evolvingdiagnosticcriteriaforarrhythmogeniccardiomyopathy